- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Colon
- Skin
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Qualified at King’s College London, BSc 1989, MBBS 1992
Trained in London and Reading as a junior, then moved to the Wessex Rotation for oncology training
Appointed as a consultant in April 2001
Qualifications – BSc 1989; MBBS 1992; MRCP 1995; FRCR 1998; FRCP 2009; CCST 2001
I take part in national clinical trials, including the SCOT trial, COIN trial, Pathos (in process of being set up) and other trials in the past such as QUASAR and ACT II.
Other clinical involvement: (eg departmental/ research/audit lead etc etc): Adelaide Ward lead; Foundation Programme Training Director; Enhanced Appraiser; Chair of RBH Consultant’s Committee. Previously Chair of the Thames Valley Head and Neck TSSG 2008 – 12.
Interests in Colorectal, Head and Neck and Skin cancer. Set up the skin cancer MDT in RBH with plastic surgeons and dermatologists in 2003. Am an integral member of Oxford / Reading Head and Neck cancer MDT and Reading Colorectal MDT. Have introduced H&N and Anal IMRT to all Reading patients.
Areas of interest
Colorectal; head& neck; skin
Medical secretaries
- Donna Gardner
- Berkshire Oncology Partnership Spire Dunedin Hospital 13 Bath Road READING RG1 6HH
- 0118 955 3531
- 0118 955 3519
- donna.gardner@spirehealthcare.com
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
Spire Dunedin Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
Spire Dunedin Hospital (1-5)